Ashkan Mortezavi

6PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersMedical roboticsNuclear and plasma physics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 23, 2026
Comprehensive 90-Day Morbidity Assessment Following Robot-Assisted Radical Cystectomy With Intracorporeal Diversion.

|Oct 28, 2023
Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial.

Basil Kaufmann, Elisa Raess, Florian A Schmid

|Apr 03, 2021
Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer.

Bram De Laere, Alessio Crippa, Ashkan Mortezavi

|Oct 15, 2020
Morbidity and mortality after robot-assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scientific Working Group.

Ashkan Mortezavi, Alessio Crippa, Sebastian Edeling

|May 14, 2020
Robot-assisted intracorporeal orthotopic bladder substitution after radical cystectomy: perioperative morbidity and oncological outcomes - a single-institution experience.

Abolfazl Hosseini, Ashkan Mortezavi, Siri Sjöberg

|Feb 29, 2020
Association between PSA density and prostate cancer in men without significant MRI lesions.

Ashkan Mortezavi, Martin Eklund, Martin Bergman

Pageof 1

Frequent Collaborators

1 joint publications

Tobias Nordström

1 joint publications

Alessio Crippa

1 joint publications

Sasa Pokupic

1 joint publications

Paolo Dell'Oglio